Article | August 1, 2026

AI Tools In Informed Consent: What Sponsors Need To Know About Risk

Source: BRANY
AI medical cloud technology, analyzing patient health data, artificial intelligence agents, smart medical records, digital healthcare solutions-GettyImages-2229247291

Artificial intelligence is becoming a common part of the informed consent process, but not all AI tools carry the same level of risk. While some applications simply improve formatting or assess reading level, others generate participant-facing content, draft consent language, or attempt to tailor materials for specific populations. Understanding the difference is essential for sponsors responsible for ensuring accuracy, compliance, and participant trust.

The greatest concerns arise when AI creates new content rather than edits existing information. Fluent, polished outputs can still contain factual inaccuracies, introduce bias, misrepresent risks and benefits, or overlook regulatory and institutional requirements. Even seemingly convincing visuals may contain protocol-specific errors that are easy to miss. As AI adoption grows, human oversight remains critical, particularly when reviewing risk disclosures, medical terminology, and culturally relevant communications.

Learn how to evaluate AI tools based on their function, identify where oversight is most needed, and build a risk-based approach that protects both research participants and study integrity.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader